Literatur
-
1
Berdal B P, Mehrl R, Meidell N K, Lorentzen-Styr A -M, Scheel O.
Field investigation
of tularemia in Norway.
FEMS Immunology an Medical Microbiology.
1996;
13
191-195
-
2
Berdal P P, Mehl R, Haaheim H, Loksa M, Grunow R, Burans J, Morgan C, Meyer H.
Field
detection of Francisella tularensis.
Scand J Infect Dis.
2000;
32
278-291
-
3
Burke D S.
Immununization
against tularemia: Analysis of the effectiveness of live Francisella
tularensis vaccine in prevention of laboratory-acquired tularemia.
Vet
Microbiol.
1996;
49
243-248
-
4
Conaln J W, North R J.
Early pathogenesis
of infection in the liver with the facultative intracellular bacteria
Listeria monocytogenes, Francisella tularensis, and Salomonella
typhimurium involves lysis of infected hepatocytes by leukocytes.
Inf
Immun.
1992;
60
5164-5171
-
5
Culkin S J, Rhinehart-Jones T, Elkins K L.
A
novel role for B cells in early protective immunity to an intracellular
pathogen, Francisella tularensis strain LVS.
J Immunol.
1997;
158
3277-3284
-
6 Dedié K, Bockemühl J, Kühn H, Volkmer K -J, Weinke T. Bakterielle Zoonosen. Enke,
Stuttgart 1993: 363-376.
-
7
Drabick J J, Fortier A H, Golovliov I, Shoemaker D, Sandström G.
Analysis
of active live immunization versus passive humoral immunotherapy
against attenuated and virulent strains of Francisella tularensis.
Vaccine
Res.
1996;
6
67-74
-
8
Elkins K L, Leiby D A, Winegar R K, Nacy C A, Fortier A H.
Rapid
generation of specific protective immunity to Francisella tularensis.
Inf
Immun.
1992;
60
4571-4577
-
9
Evans M E, Gregory D W, Schaffner W, McGee Z A.
Tularemia: A
30-year experience with 88 cases.
Medicine.
1985;
64
251-169
-
10 Evans M E, McGee Z A. Tularemia. I. Decker,
Philadelphia In: Kass EH, Platt R (Eds.): Current
therapy in infectious diseases 1983: 18-19
-
11
Flamm H, Wiedermann G.
Zur
Methodik der serologischen Tularämie-Diagnostik.
Zbl
Bakteriol.
1960;
180
254-263
-
12
Forsmann M, Sandström G, Sjöstedt A.
Analysis
of the 16S ribosomal DNA sequences of Francisella strains and utilization
for determination of the phylogeny of the genus and for identification
of strains by PCR.
Int J Syst Bacteriol.
1994;
44
38-46
-
13
Foshay L.
Tularemia:
A summary of certain aspects of the disease including methods for
early diagnosis and the results of serum treatment in 600 patients.
Medicine.
1940;
19
1-83
-
14
Golovliov I, Kuoppa K, Sjöstedt A, Tärnvik A, Sandström G.
Cytocine expression
in the liver of mice infected with a highly virulent strain of Francisella
tularensis.
FEMS Immunol Med Microbiol.
1996;
13
239-244
-
15 Grunow R, Splettstoesser W D. Human
target cells for the live vaccine strain of Francisella tularensis.
3rd Int. Meeting on: New approaches to bacterial vaccine development
(Abstr). Munich, Germany 1999: 23
-
16
Grunow R, Splettstoesser W, McDonald S, Otterbein C, O¿Brien T, Morgan C, Aldrich J, Hofer E, Finke E -J, Meyer H.
Detection of Francisella
tularensis in biological specimens using a capture-ELISA, an immunchromatographic
hand-held-assay, an a PCR.
Clin Diagn Lab Immunol.
2000;
7
86-90
-
17 Grunow R, Bosold A, Schmitt P, Splettstoesser W, Otterbei C, Finke E J. New approaches
for the laboratory diagnosis of tularemia - detection of
F. tularensis antigen and human serum antibodies using specific
ELISAs and Western blot (Abstracts 14P8). Regensburg, Deutschland 51.
Jahrestagung der Gesellschaft für Hygiene und Mikrobiologie,
11.-14. 10.1999 1999: 335
-
18
Gurycova D.
First
isolation of Francisella tularensis subsp. tularensis in Europe.
Europ
J. Epidemiol.
1998;
14
797-802
-
19
Hoel T, Scheel O, Nordahl S HG, Sandvik T.
Water-
and airborne Francisella trularensis biovar palaearctica isolated
from human blood.
Infection.
1991;
19
348-350
-
20
Hornick R B, Eigelsbach H.
Aerogenic immunization
of man with live tularemia vaccine.
Bacteriol Rev.
1966;
30
532-538
-
21
Jellison W L.
Dr.
Edward Francis and his first 23 isolates of Francisella tularensis.
J
Clin Microbiol.
1996;
34
2894-2896
-
22
Jusatz H J.
Dritter
Bericht über das Vordringen der Tularämie nach Mittel-
und Westeuropa über den Zeitraum von 1950 - 1960.
Z
Hyg.
1961;
148
69-93
-
23
Karttunen R, Surcel H -M, Andersson G, Erke H -PT, Herva E.
Francisella
tularensis-induced in vitro gamma interferon, tumor necrosis factor
alpha, and interleukin 2 response appear within 2 weeks of tularemia
vaccination in human beings.
J Clin Microbiol.
1991;
29
753-756
-
24
Knothe H.
Über
die Tularämie in Schleswig-Holstein.
Dtsch med Wschr.
1959;
84
906-909
-
25
Koskela P, Salminen A.
Humoral Immunity to
Francisella tularensis after natural infection.
J Clin
Microbiol.
1985;
22
973-979
-
26
Koskela P, Herva E.
Cell-mediated immunity
against Francisella tularensis after natural infection.
Scand
J Infect Dis.
1980;
12
281-287
-
27
Koskela P, Herva E.
Immunity against Francisella
tularensis in northern Finland.
Scand J Infect Dis.
1982;
14
195-199
-
28
Ohara Y, Sato T, Fujita H, Ueno T, Homma M.
Clinical
manifestation of tularemia in Japan - Analysis of 1.355
cases observed between 1924 and 1987.
Infection.
1991;
19
14-17
-
29
Olsufjev N G, Meshcherykova I S.
Subspecific
taxonomy of Francisella tularensis McCoy and and Chapin 1912.
Int
J Syst Bacteriol.
1983;
33
872-874
-
30
Pöhn H P, Rasch G.
Statistik meldepflichtiger übertragbarer
Krankheiten.
bga-Schriften.
1993;
5
1158-1159
-
31
Poquet Y, Kroca M, Halary F, Stenmark S, Peyrat M -A, Bonneville M, Fournie J J, Sjöstedt A.
Expansion
of VγVδ2 T cells is triggered by Francisella tularensis-derived
phosphoantigens in tularemia but not after tularemia vaccination.
Infect
Immun.
1998;
66
2107-2114
-
32
Preston R.
Annals
of warfare. The bioweaponeers.
The New Yorker, March.
1998;
9
52-65
-
33
Rohrbach B W, Westerman E, Istre G R.
Epidemiology
and clinical characteristics of human tularemia in Oklahoma, 1979
to 1985.
South Med J.
1991;
84
1091-1096
-
34
Saslaw S, Eigelsbach H T, Wilson H E, Prior J A, Carhart S.
Tularemia vaccine
study, I: Intracutaneous challenge.
Arch Intern Med.
1961;
107
121-133
-
35
Saslaw S, Eigelsbach H T, Prior J A, Wilson H E, Carhart S.
Tularemia vaccine
study, II: Respiratory challenge.
Arch Intern Med.
1961;
107
134-146
-
36
Schmid G P, Catino D, Suffin S C, Martone W J, Kaufmann A F.
Granulomatous
pleuritis caused by Francisella tularensis: Possible confusion with
tuberculous pleuritis.
Am Rev Respir Dis.
1983;
128
314-316
-
37
Sjöstedt A, Sandström G, Tärnvik A.
Humoral
and cell-mediated immunity in mice to a 17-kilodalton lipoprotein
of Francisella tularensis expressed by Salmonella typhimurium.
Infect
Immun.
1992;
60
2855-2862
-
38
Sjöstedt A, Eriksson U, Berglund L, Tärnvik A.
Detection of
Francisella tularensis in ulcers of patients with tularemia by PCR.
J
Clin Microbiol.
1997;
35
1045-1048
-
39
Stenmark S, Sunnemark D, Bucht A, Sjöstedt A.
Rapid local
expression of interleukin-12, tumor necrosis factor alpha, and gamma
interferon after cutaneous Francisella tularensis infection in tularemia-immune
mice.
Infect Immun.
1999;
67
1789-1797
-
40
Tärnvik A, Sandström G, Sjöstedt A.
Epidemiological
study of tularemia in Sweden 1931 - 1993.
FEMS
Immunol Med Microbiol.
1996;
13
201-204
-
41
Tärnvik A, Eriksson M, Sandström G, Sjöstedt A.
Francisella
tularensis - a model for studies of the immune response
to intracellular bacteria in man.
Immunology.
1992;
76
349-354
-
42
Taylor J P, Istre G R, McChesney T C, Satalowich F T, Parker R L, McFarland L M.
Epidemiologic
characteristics of human tularemia in the southwest-central states,
1981 - 1987.
Am J Epidemiol.
1991;
133
1032-1038
-
43
Tigertt W D.
Soviet
viable Pasteurella tularensis vaccines.
Bacteriol Rev.
1962;
26
354-373
Korrespondenz
Priv.-Doz. Dr. med. Roland Grunow
Sanitätsakademie der Bundeswehr, Institut
für Mikrobiologie Konsiliarlabor für
Tularämie
Neuherbergstraße 11
80937 München
Phone: 089/3168-3277
Fax: 089/3168-3277
Email: tbl01cn@mail.lrz-muenchen.de
